Publications by authors named "B Kirubi"
Introduction: In Pakistan, almost one-third of people who develop tuberculosis (TB) are missed by the National TB Program (NTP). A considerable number of people with TB receive treatment in the private sector but remain unnotified. This study documents the outcomes of an intervention to identify people with TB through private pharmacy engagement, building on mapping TB medicine sales in Punjab Province.
View Article and Find Full Text PDFArticle Synopsis
- The study focuses on evaluating two new diagnostic tests for tuberculosis (TB) infection, Cy-Tb and Standard F TB, which aim to improve accuracy and reduce costs in low-resource settings.
- It involves a cross-sectional trial with participants divided into three groups: those with confirmed TB, household contacts, and people without TB, comparing these tests with a standard reference test, QFT-Plus.
- Ethical approval has been obtained, and the research findings will be shared with the scientific community and policymakers through publications.
Active case finding (ACF) is a strategy that aims to identify people with tuberculosis (TB) earlier in their disease. This outreach approach may lead to a reduction in catastrophic cost incurrence (costs exceeding 20% of annual household income), a main target of WHO's End TB Strategy. Our study assessed the socio-economic impact of ACF by comparing patient costs in actively and passively detected people with TB.
View Article and Find Full Text PDFBackground: It is well known that poverty is associated with ill health and that ill health can result in direct and indirect costs that can perpetuate poverty. Social protection, which includes policies and programmes intended to prevent and reduce poverty in times of ill health, could be one way to break this vicious cycle. Social protection, particularly cash transfers, also has the potential to promote healthier behaviours, including healthcare seeking.
View Article and Find Full Text PDFBackground: Despite free diagnosis and treatment for tuberculosis (TB), the costs during treatment impose a significant financial burden on patients and their households. The study sought to identify the determinants for catastrophic costs among patients with drug-sensitive TB (DSTB) and their households in Kenya.
Methods: The data was collected during the 2017 Kenya national patient cost survey from a nationally representative sample (n = 1071).